Market Pulse44Neutral

Doximity, Inc.Opportunity Rank #81(DOCS) Intrinsic Value & DCF Analysis (2026)

Sector: Healthcare

Current Price

$20.07

Last updated: Jun 23, 2026

Price vs Intrinsic Value

$20.07
Price
$57.10
Intrinsic Value
Undervalued by 185%MOS: $45.68

Fundamental Score

98/100
Bullish

Weighted across 6 signals

Narrative Score

52/100
Weak

No change vs previous

Trend Score

14/100
Weak

As of 2026-06-22

The intrinsic value of Doximity, Inc. (DOCS) is estimated at $57.10 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $20.07, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 15.56% long-term growth rate and a 10.00% discount rate (calculated: 9.92%), reflecting expected future free cash flow and cost of capital.

The intrinsic value of Doximity, Inc. (DOCS) is estimated at $57.10 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $20.07, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 15.56% long-term growth rate and a 10.00% discount rate (calculated: 9.92%), reflecting expected future free cash flow and cost of capital.

Valuation Details

$57.10
▲ 184.50% upside
20% margin of safety: $45.68
Years: 10Growth Rate: 15.56%
Want to create your own valuation? Create a free account.

Capital Efficiency

Average Quarterly ROIC
23.01%
Cost of Capital (estimated)7%
Value StatusCreating Value

The company is earning a higher return on invested capital than it costs to raise that capital — a sign of strong, efficient value creation.

Complete historical ROIC is available with
.

Fundamental Details

98/100
BullishWeighted across 6 signals
DCF Discount
184.5% discount to price
100
FCF Yield
8.9% trailing FCF yield
100
ROIC vs WACC
ROIC 23.0% vs WACC 7.0% (3.3x)
100
Net Debt / FCF
Net cash position
100
Buybacks
Share count shrinking
80
FCF CAGR (5Y)
30.8% 5Y FCF CAGR
100
Strengths lead the score: DCF Discount, FCF Yield.

Narrative Details

52/100
Weak
Vs 6-Month Baseline:Above Avg (60th pct)Weighted across 6 recent drivers
Trend: StableConfidence: 85%Updated: 4h ago
Sources: 73 (51 News · 22 Analyst)
Drivers(last 30 days)
41 news sentiment+0.2
8 analyst downgrades-0.0
2 earnings miss-0.0
3 regulatory scrutiny+0.0
4 legal risk+0.0
Promotions/discounting-0.0

Trend Details

14/100
WeakAs of 2026-06-22308 daily bars used
Distance from 52-Week High-73.3%
6M Relative Strength vs SPY-65.0%
3M Relative Strength vs SPY-32.6%
Price vs 21 EMA29 · -3.5%
Price vs 50 EMA11 · -10.0%
21 EMA vs 50 EMA9 · -6.7%
3M RS vs SPY0 · -32.6%
6M RS vs SPY0 · -65.0%
Distance from 52W High0 · -73.3%

Investment Coach

Updating... 12d ago
BUYConfidence: 81%
Thesis
Doximity, Inc. is significantly undervalued with an estimated fair value 172.6% above its current price, supported by strong fundamentals including a high ROIC exceeding its cost of capital by 14.8 points and a healthy free cash flow yield of 8.9%. The company demonstrates robust financial health with strong buybacks and a solid free cash flow growth rate, making it a compelling buy opportunity.
Key Risk
A key risk is if the valuation discount narrows below 10% or if the ROIC falls below the cost of capital, which could undermine the investment thesis.
Signals To Watch
  • Monitor whether valuation discount remains above 10%.
  • Confirm ROIC stays above cost of capital over coming quarters.
  • Follow narrative trend for meaningful shifts in the score direction.
Ask the Coach - Available with
Historical Growth Rates
Free Cash Flow- - -Trend CAGR: 27.04%5 Year CAGR: 30.81%

Free Cash Flow (in millions)

TTM2025202420232022202120202019
$335$280$190$186$132$88$30$16

How Intrinziq Estimates Fair Value

Intrinziq estimates Doximity, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Doximity, Inc.Healthcare

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.